The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
An endurance runner has set a new record by running and climbing 24 mountains over a distance of 56 miles, in 24 hours.
It is up to the Supreme Court judges to decide whether the legal dispute over Brexit is, perhaps, a red herring for something else.
Urdu, Chinese, Arabic and Polish make up the majority of languages after English.